CIITA and Hodgkins lymphoma: Ulrich Streidl and colleagues recently used RNA sequencing to identify a novel and frequently expressed CIITA-BX648577 gene fusion product in the KM-H2 Hodgkin lymphoma cell-line which was associated with decreased HLA Class II expression and increased programed cell death 1 (PDL1) on the surface of affected cells (252).